Published on 26/09/2025 11:02 AM
Sonal Varma, Managing director & chief economist- India and Asia Ex-Japan, Nomura Financial Advisory & Securities (India)
Market Watch: Shivangi Sarda, Motilal Oswal Financial Services
Sajjid Chinoy, Head of Asia Economic Research, JPMorgan
On Friday, September 26, JSW Steel Ltd.’s stock rose 1.5% from the day’s lows after the Supreme Court reversed its own ruling regarding the company’s purchase of Bhushan Power and Steel.
Supreme Court overturns its earlier judgment and approves JSW’s resolution plan for Bhushan Steel.
Gopal Kabra, CEO & CMD of GK Energy
Habil F Khorakiwala, Founder and Chairman of Wockhardt Group, clarified that the antibiotic Zaynich is manufactured entirely in Europe, not India, and therefore will be subject to European tariffs rather than Indian tariffs.
Read Full Article
Samiran Chakraborty, Chief Economist, India, Citi
Soumya Kanti Ghosh, Group Chief Economic Advisor, State Bank of India
All major sectoral indices are trading in the red. However, the Auto sector index is the only one trading in green with marginal gains.
Balaji Subramanian, VP of IIFL Capital Services, says the focus on Vodafone Idea has shifted to whether the Supreme Court grants the government leeway in resolving the adjusted gross revenue (AGR) matter. With a 49% stake in the company, the government aims to maintain a three-player telecom market and is seeking official clarity from the Court before pursuing relief measures, such as extending moratoriums, adjusting payment timelines, or changing the NPV of liabilities. The tone has turned positive, pending the Court’s decision.
Aarti Drugs shares fell 6.02% to ₹476.55 on September 26, down from the previous close of ₹507.10.
The stock, part of BSE 1000 and BSE AllCap, has a market capitalisation of ₹4,349.47 crore and a traded volume of 1,51,840 shares.
Over the past five trading sessions, the stock has declined 7.76%, with a price-to-earnings (P/E) ratio of 25.97.
The Nifty Pharma index is under pressure after Donald Trump’s tariff threat on pharma
The indebted telecom company’s appeal against the Central government’s demand for Adjusted Gross Revenue (AGR) is scheduled to be heard by the Supreme Court today.
The hearing, which was postponed from last week, is probably going to start at 11 a.m. today.
GK Energy shares had a strong debut on Friday, September 26, listing at ₹171 on the NSE, up 11.76% from the IPO price of ₹153. On the BSE, shares opened at ₹165, a 7.8% premium.
Read Full Article
Vinkesh Gulati, Director, United Automobiles & Past President
CS Vigneshwar, President, Federation of Automobile Dealers Associations (FADA)
SpiceJet has finalised a lease agreement to bring in a wide-body Airbus A340 aircraft, which is scheduled to arrive by the end of this month and is expected to commence operations in the first week of October.
Saatvik Green Energy made a muted debut on Dalal Street on Friday, September 26, listing slightly below its issue price. Shares opened at ₹460 on the BSE, down 1.07% from ₹465, while on the NSE, the stock listed at par.
Read Full Article
GK Energy Lists At ₹171/Sh Vs Issue Price Of ₹153/Sh On NSE
Railtel has received a Letter of Award (LoA) for a project valued at ₹970 crore from the Bihar Education Project Council.
Carysil, a manufacturer and exporter of home furnishing products including kitchen sinks and appliances, is in focus on Friday, September 26, following recent US tariff-related developments.
Read Full Article
Slight recovery in the market; Nifty above 24,800, rebounds over 50 points from day’s low
Habil Khorakiwala, Founder & Chairman of Wockhardt Group, highlights that 40% of US generics are made in India, warning that regulations on generics could severely affect US drug prices.
He notes that Trump’s 100% tariff on branded drugs won’t impact the company’s plans to launch the antibiotic Zaynich in the US.
Sun Pharma
The shares of Caplin Point Labs declined along with other pharma stocks.
Sanjay Parekh of Sohum Asset Managers says markets remain jittery due to ad hoc tariffs and H-1B visa uncertainty, making the near-term outlook challenging.
He remains underweight on IT but holds Infosys, and is overweight on telecom, increasing exposure to Bharti Airtel as a structural play with ARPU growth potential.
The shares of Natco Pharma have declined over 3%.
These are the top Nifty contributors as the index falls over 100 points
Waaree Energies fell nearly 5% following reports that the company is under a US investigation for allegedly evading solar tariff duties.
NewsLive TVMarketPopular CategoriesCalculatorsTrending NowLet's Connect with CNBCTV 18Network 18 Group :©TV18 Broadcast Limited. All rights reserved.